Sean Brynjelsen
Vorstandsvorsitzender bei ETON PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Sean Brynjelsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ETON PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.06.2017 | - |
| Vorstandsvorsitzender | 01.06.2017 | - | |
| Präsident | 01.06.2017 | - |
Karriereverlauf von Sean Brynjelsen
Ehemalige bekannte Positionen von Sean Brynjelsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | 23.03.2016 | 01.06.2017 |
| AKORN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.06.2010 | 07.02.2014 |
| Corporate Officer/Principal | 07.02.2014 | 01.03.2016 |
Ausbildung von Sean Brynjelsen
| University of Notre Dame | Masters Business Admin |
| University of Illinois | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Börse
- Insiders
- Sean Brynjelsen
- Erfahrung
